Journal Article Summary
The article investigates the persistence of various antiepileptic drugs (AEDs) in patients with epilepsy, focusing on the importance of treatment adherence. Persistence, which refers to how long patients continue their prescribed medication, is crucial for managing epilepsy effectively. Understanding which AEDs are more likely to be adhered to can help healthcare providers make better treatment decisions, especially since managing epilepsy can be complicated by factors like side effects and drug interactions.
In this study, researchers analyzed data from Taiwan's National Health Insurance Research Database, including over 13,000 adult patients who started treatment with one of seven AEDs between 2005 and 2009. They measured persistence by tracking how long patients continued their prescribed AEDs before switching, stopping, or being hospitalized due to seizures. The findings revealed that patients taking oxcarbazepine, valproic acid, lamotrigine, and topiramate had better persistence compared to those on carbamazepine, while phenytoin users showed a higher risk of discontinuation.
Despite the study's strengths, such as a large sample size and comprehensive data, there are limitations to consider. The researchers could not confirm whether patients actually took their medications, as the study relied on prescription data. Patients and caregivers should discuss these findings with healthcare professionals to understand how medication choices might affect treatment adherence and overall management of epilepsy. It's essential to consider individual health conditions and potential side effects when selecting an AED.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Lai Edward Chia-Cheng, Hsieh Cheng-Yang, Su Chien-Chou, Yang Yea-Huei Kao, Huang Chin-Wei, Lin Swu-Jane, Setoguchi Soko. Comparative persistence of antiepileptic drugs in patients with epilepsy: A STROBE-compliant retrospective cohort study. Medicine 2016. DOI: 10.1097/MD.0000000000004481. PMID: 27583857. PMCID: PMC5008541.
Featured Pill Pals Product
Gabapentin 100 mg Capsules --- 30 Count --- Amneal Pharma --- Generic for Neurontin --- Total Dose = 1 Pill / Day --- 30 Day's Supply
Gabapentin 100 mg Capsules — 30 Count — Amneal Pharma — Generic for Neurontin — Total Dose = 1 Pill / Day — 30 Day’s Supply is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
